Xanthippi Tzannetakou

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Despite its effectiveness in the treatment of malignant tumors, bevacizumab is associated with a variety of side effects such as the formation of fistulas (i.e., tracheoesophageal, colovaginal, or rectovaginal). It is important to recognize immediately the emergence of this entity in order to discontinue bevacizumab permanently and treat the fistula.
  • 1